PRESS AND PUBLICATIONS

You will find in this section all the publications and press releases.

PRESS RELEASES

Increasing the life span of grafted kidneys, Press release by the INSERM for the launch of the BioMargin project

Pdf available here: FR version UK version

PUBLICATIONS

2018

Precision Transplant Medicine: Biomarkers to the Rescue                                                                                        Maarten Naesens,Dany Anglicheau

2017

Foretelling Graft Outcome by Molecular Evaluation of Renal Allograft Biopsies
Saleh Yazdani , Maarten Naesens
Transplantation, 01/01/2017

2016

Establishing Biomarkers in Transplant Medicine
Dany Anglicheau , Maarten Naesens , Marie Essig , Wilfried Gwinner , Pierre Marquet
Transplantation, 01/01/2016

BioMargin Publishable Summary (August 2014-February 2016)

The role of urinary peptidomics in kidney disease research
Klein J, Bascands JL, Mischak H, Schanstra JP
Kidney International, 14/01/2016

2015

miRNAs in urine: a mirror image of kidney disease?
Papadopoulos T, Belliere J, Bascands JL, Neau E, Klein J, Schanstra JP.
Expert Rev Mol Diagn. 2015 Feb 8:1-14. [Epub ahead of print]
PMID: 25660955 [PubMed - as supplied by publisher]

2014

MicroRNAs as biomarkers of graft outcome
Amrouche L, Rabant M, Anglicheau D
Transplant Rev (Orlando). 2014 Jul;28(3):111-8. doi: 10.1016/j.trre.2014.03.003. Epub 2014 Mar 27

BioMargin Publishable Summary (March 2013-August 2014)

 ABTRACTS

2017

FP7 biomargin: small sets of urinary cell mrnas leading to a partition tree on kidney allograft lesions
C. Tinel, A. Benon,L. Morin, S. Gazut, M. Naesens, W. Gwinner, M. Essig, P. Marquet, D. Anglicheau

FP7 BioMargin shows that a small set of blood micrornas is associated with acute kidney allografts rejection      
C. Tinel, A. Benon, S. Gazut, M. Naesens, W. Gwinner, M. Essig, P. Marquet, D. Anglicheau

FP7 BioMargin shows that small sets of intra-graft micrornas are strongly associated with renal allograft lesions   
C. Tinel, A. Benon, S. Gazut, M. Naesens, W. Gwinner, M. Essig, P. Marquet, D. Anglicheau

FP7 BioMargin: urinary protein biomarkers of renal graft injuries in kidney allograft recipients    
Willems H., Schildermans K., Baggerman G., Naesens M., Gwinner W., Anglicheau D., Essig M., Marquet P., Mertens I

FP7 BioMargin shows that a small set of urinary peptides can diagnose acute kidney graft rejection accurately
F.L Sauvage J.B. Woillard, M. Naesens, D. Anglicheau, W. Gwinner, L.H. Noel, I. Brocheriou, M. Essig, P. Marquet, on behalf of the BIOMARGIN consortium            

Activated natural killer cells predict graft outcome in kidney transplantation
Yazdani S, Gazut S, Heylen L, Thorrez L, Anglicheau D, Gwinner W, Essig M, de Loor J, Van Lommel L, Schuit F, Schindelé A,Rinaudo Ph, Benhabiles N, Marquet P, Naesens M

Activated natural killer cells and activity of antibody-mediated rejection in kidney transplantation: : BioMargin case-control study
Yazdani S, Gazut S, Heylen L, Thorrez L, Anglicheau D, Gwinner W, Essig M, de Loor J, Van Lommel L, Schuit F, Schindelé A,Rinaudo Ph, Benhabiles N, Marquet P, Naesens M

 2014

“Mass spectrometry in pharmacology and toxicology: routine, specialized and research applications”
Pierre MARQUET,   UMR 850 INSERM/Univ. Limoges/CHU Limoges (France)
Congrès Français de Spectométrie de Masse et d'Analyse Protéomique
SMAP 2014, 30 Juin, Lyon (FR)